Cynthia Bedell - Concepedia

Concepedia

Author

Cynthia Bedell

Mary Crowley Cancer Research Center

Also Known As

Cynthia Bedell, Cynthia H. Bedell

37

Publications

1.1K

Citations

11

H-Index

12

Concepts

All Affiliations

Mary Crowley Cancer Research Center Texas Oncology Gradalis (United States)Medical City Dallas Hospital Cardiovascular Research Associates

CB

About

Cynthia Bedell is an author at Mary Crowley Cancer Research Center specializing in tumor biology, immunotherapy, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	15
2	Cell Biology	1	1	15
3	Immunology	1	1	15
4	Pathology	1	1	15
5	Immunotherapy	1	1	15

Cynthia Bedell

×

11

Publications

1.1K

Citations

11

H-Index

	Year	Citations
A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors John Nemunaitis, Alex W. Tong, Michael Nemunaitis, Molecular Therapy	2009	265
Phase I Study of a Systemically Delivered p53 Nanoparticle in Advanced Solid Tumors Neil Senzer, John Nemunaitis, Derek Nemunaitis, Molecular Therapy	2013	236
Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer Neil Senzer, Minal Barve, Joseph A. Kuhn, Molecular Therapy	2011	193
Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors Geoffrey I. Shapiro, Jordi Rodón, Cynthia Bedell, Clinical Cancer Research	2013	149
Phase I Dose-Escalation Study of the Multikinase Inhibitor Lenvatinib in Patients with Advanced Solid Tumors and in an Expanded Cohort of Patients with Melanoma David S. Hong, Razelle Kurzrock, Jennifer J. Wheler, Clinical Cancer Research	2015	69
Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine Jairo Olivares, Padmasini Kumar, Yang Yu, Clinical Cancer Research	2011	54
Summary of bi-shRNA<sup>furin</sup>/GM-CSF Augmented Autologous Tumor Cell Immunotherapy (FANG™) in Advanced Cancer of the Liver John Nemunaitis, Minal Barve, Douglas Orr, Oncology	2014	49
Hereditary Inclusion Body Myopathy: Single Patient Response to Intravenous Dosing of <i>GNE</i> Gene Lipoplex Gregory Nemunaitis, Chris Jay, Phillip B. Maples, Human Gene Therapy	2011	49
Hereditary inclusion body myopathy: single patient response to <i>GNE</i> gene Lipoplex therapy Gregory Nemunaitis, Phillip B. Maples, Chris Jay, The Journal of Gene Medicine	2010	27
Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer Minal Barve, Zhaohui Wang, Padmasini Kumar, Molecular Therapy	2015	20

Page 1